Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
New England Journal of Medicine · 01.08.2024 · 391 (5) · 393-407
DOI: 10.1056/nejmoa2405090 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 01.08.2024. Verfasst von Vania Hungria und 40 weiteren Autor:innen. Beteiligte Einrichtung: From Clinica São Germano (V.H.) and Hospital das Clínicas and Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo (G.A.M.), São Pau…. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Bortezomib, Dexamethasone, Multiple Myeloma. Die Arbeit wurde bisher 208-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: GlaxoSmithKline.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From Clinica São Germano (V.H.) and Hospital das Clínicas and Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo (G.A.M.), São Paulo, Centro de Pesquisa e Ensino em Saúde de Santa Catarin, Florianópol…
ORCID-Profile: Marcelo Pitombeira de Lacerda, Claudio Cerchione, Nick Pirooz
Förderung
- GlaxoSmithKline
Zitieren
APA
Hungria, V., Robak, P., Hus, M., Zherebtsova, V., Ward, C., Ho, P. J., Ribas de Almeida, A. C., Hajek, R., Kim, K., Grosicki, S., Sia, H., Bryant, A., Pitombeira de Lacerda, M., Aparecida Martinez, G., Sureda Balarí, A. M., Sandhu, I., Cerchione, C., Ganly, P., Dimopoulos, M., …, & DREAMM-7 Investigators (2024). Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma. New England Journal of Medicine, 391(5), 393-407. https://doi.org/10.1056/nejmoa2405090
Vancouver
Hungria V, Robak P, Hus M, Zherebtsova V, Ward C, Ho PJ, et al. Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma. New England Journal of Medicine. 2024;391(5):393-407. doi:10.1056/nejmoa2405090
BibTeX
@article{Hungria2024,
author = {Hungria, Vania and Robak, Pawel and Hus, Marek and Zherebtsova, Vera and Ward, Christopher and Ho, P Joy and Ribas de Almeida, Ana Carolina and Hajek, Roman and Kim, Kihyun and Grosicki, Sebastian and Sia, Hanlon and Bryant, Adam and Pitombeira de Lacerda, Marcelo and Aparecida Martinez, Gracia and Sureda Balarí, Anna Maria and Sandhu, Irwindeep and Cerchione, Claudio and Ganly, Peter and Dimopoulos, Meletios and Fu, Chengcheng and Garg, Mamta and Abdallah, Al-Ola and Oriol, Albert and Gatt, Moshe E and Cavo, Michele and Rifkin, Robert and Fujisaki, Tomoaki and Mielnik, Michał and Pirooz, Nick and McKeown, Astrid and McNamara, Simon and Zhou, Xiangdong and Nichols, Maureen and Lewis, Eric and Rogers, Rachel and Baig, Hena and Eccersley, Lydia and Roy-Ghanta, Sumita and Opalinska, Joanna and Mateos, María-Victoria and DREAMM-7 Investigators, DREAMM-7 Investigators},
title = {Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma},
journal = {New England Journal of Medicine},
year = {2024},
volume = {391},
number = {5},
pages = {393--407},
doi = {10.1056/nejmoa2405090}
}
EUVIMED